What is Concord Biotech Ltd (CONCORDBIO) share price today?

Concord Biotech Ltd (CONCORDBIO) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/CONCORDBIO for the latest live price, technical analysis, and AI-powered insights.

How to analyse CONCORDBIO stock?

VestAI provides comprehensive CONCORDBIO stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Concord Biotech Ltd in?

Concord Biotech Ltd (CONCORDBIO) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Concord Biotech Ltd

Q: What is Concord Biotech Ltd's Orion Score?

Concord Biotech Ltd has an Orion Score of 63/100 (Watch) — a fundamentals-based quality & risk score. Concord Biotech Ltd scores 63/100 (Watch) on the Orion Score — strong business quality (81), poor growth (25), strong balance-sheet safety (94) and rich valuation (21). A fundamentals-based quality & risk score, not a buy/sell recommendation.

CONCORDBIO

NSE· Healthcare

₹1,342.80

+15.20 (+1.14%)

Updated 08:01 am IST

52W Low · ₹987.0052W High · ₹1,980.00

Mid Range

Market Cap

₹13649.28L Cr

Volume

66.5K

Prev Close

₹1,351.70

ISIN

INE338H01029

Orion Score

Fundamentals-based quality & risk · not a recommendation

63/100

Watch

Concord Biotech Ltd scores 63/100 (Watch) on the Orion Score — strong business quality (81), poor growth (25), strong balance-sheet safety (94) and rich valuation (21). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Short track record (3 yrs of data)

Forensic accounting

Piotroski F 4/9Altman Z Safe(16.06)Beneish M Clean(-2.56)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

49/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.00x — lean balance sheet

QUALITY

Average

ROCE 14.8% — decent returns

MOMENTUM

Neutral

RSI 61.6 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 52.61
ROCE: 14.76%
ROE (1Y): 13.54%
D/E Ratio: 0.00x
OPM: 30.36%
TTM EPS: ₹24.80
Dividend Yield: 58.00%
Qtrly Sales: ₹326.08 Cr
Qtrly Profit: ₹88.79 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹326.08	₹88.79	30.4%	₹8.46
Q3 2026	₹277.77	₹63.64	28.9%	₹6.08
Q2 2026	₹247.06	₹63.06	28.4%	₹6.03
Q1 2026	₹203.99	₹44.06	21.4%	₹4.21
Q4 2025	₹429.88	₹140.39	40.9%	₹13.42

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹1,054.89	₹260.91	₹419.39	27.8%
FY 2025	₹1,200.09	₹371.64	₹549.46	37.7%
FY 2024	₹998.06	₹308.1	₹468.71	38.7%
FY 2023	₹830.63	₹240.09	₹380.56	36.7%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
CONCORDBIO ★	₹13,649 Cr	52.61	14.76%	13.54%	0.00x	30.36%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹2,034.25	₹1,700.71	₹1,513.98	₹1,312.8
Equity	₹1,812.72	₹1,526.65	₹1,290	₹1,103.22
Total Debt	₹2.97	₹9.74	₹31.55	₹62.49
Cash	₹0.9	₹15.14	₹3.5	₹0.67
Net Debt	—	—	₹27.74	₹59.92
Working Capital	₹951.18	₹754.08	₹535.86	₹477.5

Shareholding Pattern

Q1 FY2027

Promoter

74.26%

FII

6.9%

DII

5.64%

Public

13.2%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	74.26% ↓	6.9% ↓	5.64% ↓	13.2% ↑
Q4 FY2026	74.65% ↑	6.94% ↓	5.68% ↓	12.73% ↓
Q3 FY2026	44.08%	7.58% ↓	9.58% ↑	38.75% ↑
Q2 FY2026	44.08%	8.03% ↓	9.55% ↑	38.32% ↑
Q1 FY2026	44.08%	9.1% ↓	8.85% ↓	37.94% ↑
Q4 FY2025	44.08%	9.35% ↑	9.16% ↓	37.41% ↓
Q3 FY2025	44.08%	8.33% ↑	9.65% ↓	37.93% ↓
Q2 FY2025	44.08%	8.1%	9.89%	37.95%

Corporate Actions

No recent corporate actions

Smart Money Holdings

Q4 FY2025

Investor	Shares Held	Portfolio %	Change
Rekha JJ	8,00,000	7.21%	—

Funds Holding This Stock

43 mutual fund schemes

SBI Healthcare Opportunities Fund Direct Plan GrowthSBI

1.66%

₹76 Cr

DSP Healthcare Fund Direct GrowthDSP

1.58%

₹52 Cr

Baroda BNP Paribas Health and Wellness Fund Direct GrowthBARODABNPPARIBASMUTUALFUND_MF

1.45%

₹8 Cr

ITI Flexi Cap Fund Direct GrowthITI

1.00%

₹13 Cr

Baroda BNP Paribas Innovation Fund Direct GrowthBARODABNPPARIBASMUTUALFUND_MF

0.96%

₹8 Cr

Edelweiss Small Cap Fund Direct GrowthEDELWEISS

0.79%

₹49 Cr

Tata India Pharma & Healthcare Fund Direct GrowthTATA

0.77%

₹11 Cr

DSP Small Cap Direct Plan GrowthDSP

0.76%

₹140 Cr

Bandhan Healthcare Fund Direct GrowthIDFC

0.68%

₹2 Cr

Invesco India Aggressive Hybrid Fund Direct GrowthINVESCO

0.58%

₹4 Cr

Analyse CONCORDBIO with Orion AI

Ask: "Is Concord Biotech Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Concord Biotech Ltd (CONCORDBIO) Stock

Concord Biotech Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE338H01029. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.